The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 13 members with Joerg Reinhardt as chair.

Download the Board of Director Committee Organizational Chart (PDF 0.1 MB)

Joerg Reinhardt, Ph.D., Board Chair
Chair
Joerg Reinhardt, Ph.D.
Simon Moroney, Board member
Board member since 2020 | Vice-Chair since March 4, 2022
Simon Moroney, D.Phil.
Nancy C. Andrews, M.D., Ph.D., Board member
Board member since 2015
Nancy C. Andrews, M.D., Ph.D.
Ton Buechner, Board member
Board member since 2016
Ton Buechner
Patrice Bula, Board member
Board member since 2019 | Lead Independent Director since March 4, 2022
Patrice Bula
Elizabeth (Liz) Doherty, Board member
Board member since 2016
Elizabeth (Liz) Doherty
Bridgette Heller, Board member
Board member since 2020
Bridgette Heller
Daniel Hochstrasser, Board member
Member of the Board of Directors since March 4, 2022
Daniel Hochstrasser
Frans van Houten, Board member
Board member since 2017
Frans van Houten
Andreas von Planta, Ph.D., Board member
Board member since 2006
Andreas von Planta, Ph.D.
Ana de Pro Gonzalo, Board member
Board member since March 4, 2022
Ana de Pro Gonzalo
Charles L. Sawyers, M.D., Board member
Board member since 2013
Charles L. Sawyers, M.D.
William T. Winters, Board member
Board member since 2013
William T. Winters
Charlotte Pamer-Wieser, Ph.D., Corporate Secretary
Corporate Secretary
Charlotte Pamer-Wieser, Ph.D.